These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6717857

  • 1. The cholecystokinin analogue, caerulein, does not modulate dopamine release or dopamine-induced locomotor activity in the nucleus accumbens of rat.
    Hamilton M, Sheehan MJ, De Belleroche J, Herberg LJ.
    Neurosci Lett; 1984 Jan 27; 44(1):77-82. PubMed ID: 6717857
    [Abstract] [Full Text] [Related]

  • 2. Caerulein peripheral injection: a study on the correlation with dopaminergic metabolism.
    Pasinetti G, Govoni S, Battaini F, Locatelli P, Faccini E, Trabucchi M.
    Pharmacol Res Commun; 1984 Dec 27; 16(12):1175-82. PubMed ID: 6522441
    [Abstract] [Full Text] [Related]

  • 3. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F, Ettenberg A, Koob GF.
    Psychopharmacology (Berl); 1989 Dec 27; 99(3):409-15. PubMed ID: 2574480
    [Abstract] [Full Text] [Related]

  • 4. Cholecystokinin octapeptide and caerulein injection into the dorsomedial nucleus accumbens potentiate apomorphine-induced jaw movements in rats.
    Koshikawa N, Kikuchi de Beltrán K, Saigusa T, Kobayashi M, Stephenson JD.
    Eur J Pharmacol; 1991 Dec 10; 209(1-2):75-80. PubMed ID: 1814762
    [Abstract] [Full Text] [Related]

  • 5. Differential effects of ceruletide on amphetamine-induced behaviors and regional dopamine release in the rat.
    Kihara T, Ikeda M, Matsubara K, Matsushita A.
    Eur J Pharmacol; 1993 Jan 19; 230(3):271-7. PubMed ID: 8440305
    [Abstract] [Full Text] [Related]

  • 6. Association of the mesencephalic locomotor region with locomotor activity induced by injections of amphetamine into the nucleus accumbens.
    Brudzyński SM, Mogenson GJ.
    Brain Res; 1985 May 13; 334(1):77-84. PubMed ID: 2986781
    [Abstract] [Full Text] [Related]

  • 7. Specificity of nucleus accumbens to activities related to cholecystokinins in rats.
    Katsuura G, Itoh S, Hsiao S.
    Peptides; 1985 May 13; 6(1):91-6. PubMed ID: 3991366
    [Abstract] [Full Text] [Related]

  • 8. Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.
    Swerdlow NR, Amalric M, Koob GF.
    Pharmacol Biochem Behav; 1987 Apr 13; 26(4):765-9. PubMed ID: 3110795
    [Abstract] [Full Text] [Related]

  • 9. Effect of a novel environment on locomotor hyperactivity of rats induced by apomorphine in the nucleus accumbens.
    Morgenstern R, Fink H.
    Biomed Biochim Acta; 1985 Apr 13; 44(10):1517-22. PubMed ID: 4084255
    [Abstract] [Full Text] [Related]

  • 10. Nucleus accumbens cholecystokinin (CCK) can either attenuate or potentiate amphetamine-induced locomotor activity: evidence for rostral-caudal differences in accumbens CCK function.
    Vaccarino FJ, Rankin J.
    Behav Neurosci; 1989 Aug 13; 103(4):831-6. PubMed ID: 2765186
    [Abstract] [Full Text] [Related]

  • 11. Dopamine denervation of frontal cortex or nucleus accumbens does not affect ACTH-induced grooming behaviour.
    Dunn AJ, Alpert JE, Iversen SD.
    Behav Brain Res; 1984 Jun 13; 12(3):307-15. PubMed ID: 6087843
    [Abstract] [Full Text] [Related]

  • 12. Stimulatory effect of N-methyl aspartate on locomotor activity and transmitter release from rat nucleus accumbens.
    Hamilton MH, De Belleroche JS, Gardiner IM, Herberg LJ.
    Pharmacol Biochem Behav; 1986 Nov 13; 25(5):943-8. PubMed ID: 2878446
    [Abstract] [Full Text] [Related]

  • 13. Behavioral evidence for cholecystokinin modulation of dopamine in the mesolimbic pathway.
    Crawley JH.
    Prog Clin Biol Res; 1985 Nov 13; 192():131-8. PubMed ID: 4080706
    [Abstract] [Full Text] [Related]

  • 14. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK, Jackson DM.
    Brain Res; 1989 May 22; 487(2):267-77. PubMed ID: 2525062
    [Abstract] [Full Text] [Related]

  • 15. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF, Blaha CD, Phillips AG.
    Brain Res; 1986 Nov 05; 397(1):200-4. PubMed ID: 3801862
    [Abstract] [Full Text] [Related]

  • 16. Pharmacological and mechanistic studies of cholecystokinin-facilitated [3H]dopamine efflux from rat nucleus accumbens.
    Vickroy TW, Bianchi BR.
    Neuropeptides; 1989 Jan 05; 13(1):43-50. PubMed ID: 2466220
    [Abstract] [Full Text] [Related]

  • 17. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN, Hommer DW, Skirboll LR.
    Brain Res; 1985 Jun 03; 335(2):337-41. PubMed ID: 4005562
    [Abstract] [Full Text] [Related]

  • 18. Biphasic locomotor response to intra-accumbens dopamine in a nonhuman primate.
    Jones DL, Berg SL, Dorris RL, Dill RE.
    Pharmacol Biochem Behav; 1981 Aug 03; 15(2):243-6. PubMed ID: 7198267
    [Abstract] [Full Text] [Related]

  • 19. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
    Voigt MM, Wang RY, Westfall TC.
    J Neurosci; 1985 Oct 03; 5(10):2744-9. PubMed ID: 4045551
    [Abstract] [Full Text] [Related]

  • 20. Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat.
    Kafetzopoulos E.
    Psychopharmacology (Berl); 1986 Oct 03; 88(3):271-4. PubMed ID: 3083447
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.